NCT04872244View on ClinicalTrials.gov

Can Intrauterine Levonorgestrel Releasing Device Be a Treatment Option for Postmenstrual Spotting in Isthmocele

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 3, 2019

Primary Completion Date

June 3, 2021

Study Completion Date

July 12, 2021

Conditions

IsthmocelePost-menstrual Spotting BleedingPelvic Pain

Interventions

DEVICE

usage of mirena ( levonorgestrel releasing intrauterine device) in isthmocele

usage of mirena ( levonorgestrel releasing intrauterine device) in isthmocele for postmenstrual spotting and do not have desire for fertility

DRUG

Levonorgestrel Drug Implant Product

intrauterine administration

Trial Locations (1)

34245

saglik Bilimleri Univercity Gaziosmanpaşa Training and Research Hospital, Istanbul

All Listed Sponsors

lead

Gaziosmanpasa Research and Education Hospital

OTHER_GOV

NCT04872244 - Can Intrauterine Levonorgestrel Releasing Device Be a Treatment Option for Postmenstrual Spotting in Isthmocele | Biotech Hunter | Biotech Hunter